Effects of systemic PACAP treatment in monosodium glutamate-induced behavioral changes and retinal degeneration

Annals of the New York Academy of Sciences

Volumn 1070, Issue , 2006, Pages 365-370

  Kiss, P ^a   Tamas A ^a   Lubics, A ^a   Lengvari I ^c   Szalai, M ^a   Hauser, D ^a   Horvath, Z S ^a   Racz, B ^a   Gabriel, R ^a   Babai, N ^a   Toth, G ^b   Reglodi D ^a  

^a UNIVERSITY OF PÉCS   (Hungary)

^b UNIVERSITY OF SZEGED   (Hungary)

^c University of Pécs ^*

Author keywords

Neonatal rat; Neurobehavioral development; Retinotoxicity

Indexed keywords

GLUTAMATE SODIUM; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; BEHAVIOR CHANGE; COGNITION; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFECT; FEMALE; FORELIMB; GAIT; MALE; MOTOR COORDINATION; NEWBORN; NEWBORN PERIOD; NONHUMAN; RETINA DEGENERATION; RIGHTING REFLEX;

EID: 33746417939     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1317.046     Document Type: Conference Paper

References (14)

1. WASCHEK, J.A. 2002. Multiple actions of pituitary adenylyl cyclase activating peptide in nervous system development and regeneration. Dev. Neurosci. 24: 14-23.
2. SOMOGYVARI-VIGH, A. & D. REGLODI. 2004. Pituitary adenylate cyclase activating polypeptide: a potential neuroprotective peptide. Review. Curr. Pharm. Des. 10: 2861-2889.
3. VAUDRY, D. et al. 2000. PACAP acts as a neurotrophic factor during histogenesis of the rat cerebellar cortex. Ann. N. Y. Acad. Sci. 921: 293-299.
4. GRESSENS, P. et al. 2000. VIP and PACAP38 modulate ibotenate-induced neuronal heteroropias in the newborn hamster neocortex. J. Neuropathol. Exp. Neurol. 59: 1051-1062.
5. ARIMURA, A. et al. 1994. PACAP functions as a neurotrophic factor. Ann. N. Y. Acad. Sci. 739: 228-243.
6. REGLODI, D. et al. 2003. The effects of PACAP and PACAP antagonist on the neurobehavioral development of newborn rats. Behav. Brain Res. 140: 131-139.
7. HILL, J.M. et al. 1991. Vasoactive intestinal peptide antagonist retards the development of neonatal behaviors in the rat. Peptides 12: 187-192.
8. KISS, P. et al. 2005. Development of neurological reflexes and motor coordination in rats neonatally treated with monosodium glutamate. Neurotox. Res. 8: 235-244.
9. TAMAS, A. et al. 2004. Effects of pituitary adenylate cyclase activating polypeptide in retinal degeneration induced by monosodium-glutamate. Neurosci. Lett. 372: 110-113.
10. BABAI, N. et al. 2005. Degree of damage compensation by various PACAP treatments in monosodium glutamate-induced retina degeneration. Neurotox. Res. 8: 227-233.
11. BANKS, W.A. et al. 1996. Transport of pituitary adenylate cyclase activating polypeptide across the blood-brain barrier and the prevention of ischemia-induced death of hippocampal neurons. Ann. N. Y. Acad. Sci. 805: 270-277.
12. REGLODI, D. et al. 2000. Neuroprotective effects of PACAP38 in a rat model of transient focal ischemia under various experimental conditions. Ann. N. Y. Acad. Sci. 921: 119-128.
13. ALTMAN, J. & K. SUDARSHAN. 1975. Postnatal development of locomotion in the laboratory rat. Anim. Behav. 23: 896-920.
14. SMART, J.L. & J. DOBBING. 1971. Vulnerability of developing brain. II. Effects of early nutritional deprivation on reflex ontogeny and development on behavior in the rat. Brain Res. 28: 85-95.